Valeant Pharmaceuticals International Announces Redemption of All Outstanding 7% Senior Notes Due 2011
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE: VRX - News) today announced that it will redeem all of the $300 million aggregate principal amount outstanding of its 7% Senior Notes due 2011 (CUSIP No. 91911XAG9) (the "Notes").